Chiesi, Phenomix deal

Phenomix granted Chiesi exclusive rights to develop and commercialize dutogliptin (PHX1149) in Europe, Brazil, the Commonwealth of Independent States, Turkey and Northern Africa. The dipeptidyl pepti...